期刊文献+

原发性肺非霍奇金淋巴瘤的临床特点及预后分析 被引量:1

Clinical characteristics and prognosis of primary pulmonary non-Hodgkin's lymphoma
下载PDF
导出
摘要 目的研究原发性肺非霍奇金淋巴瘤(PPL)的临床特征及预后。方法回顾性分析北京协和医院确诊的30例PPL的临床表现、诊断手段、病理类型以及预后。结果病例中,男性占46.7%,中位年龄为46岁。PPL患者没有特异的临床症状及影像学表现,甚至20%患者可无任何症状。中位发病至诊断时间为8个月,经支气管肺活检及经CT引导下肺活检的诊断率分别为33.3%和50%,而胸腔镜下肺活检及开胸肺活检的诊断率为100%。黏膜相关淋巴组织(MALT)淋巴瘤最为常见,占56.7%。在中位随诊39个月后,30例患者中有7例患者(23.3%)死亡。MALT组患者较非MALT组患者有着更低的IPI评分及更好的预后。结论 PPL是一种罕见的结外淋巴瘤,其诊断较为困难,非MALT类型的淋巴瘤患者预后较差。 Objective To study the clinical characteristics and outcome of patients with primary pulmonary non-Hodgkin's lymphoma(PPL).Methods The clinical features,diagnostic methods,pathological types and outcome of 30 patients with PPL diagnosed in PUMC Hospital were analyzed retrospectively.Results Of these 30 patients,46.7% of patients were male and the median age was 46 years.These patients didn't have specific clinical symptoms and radiological features and 20% patients were asymptomatic.The median time from onset to diagnosis of all patients was 8 months.The positive diagnostic rate of transbronchial lung biopsy,lung biopsy guided by computer tomography,and lung biopsy by thoracoscopy was 33.3%,50% and 100%,respectively.The mucosa-associated lymphoid tissue(MALT) lymphoma was the main type in PLL,which was found in 56.7% patients.Seven of 30 patients died after 39 months of median follow-up time.Compared with patients with non-MALT lymphoma,patients with MALT lymphoma had lower international prognostic index(IPI) score and better prognosis.ConclusionThe PPL is an uncommon extra-nodular lymphoma and is difficult to diagnose.The patients with non-MALT lymphoma have better prognosis in PPL.
出处 《基础医学与临床》 CSCD 北大核心 2011年第5期574-577,共4页 Basic and Clinical Medicine
关键词 非霍奇金淋巴瘤 原发性 临床特征 non-Hodgkin's lymphoma lung primary clinical characteristics
  • 相关文献

参考文献8

  • 1Ferraro P, Trastek VF, Adlakha H, et al. Primary non- Hodgkin's lymphoma of the lung [ J ]. Ann Thorac Surg, 2000, 69:993-997.
  • 2Hu YH, Hsiao LT, Yang CF, et al. Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lym- phoma: The single-institute experience in Taiwan [J]. Ann Hematol, 2009, 88:839-846.
  • 3Cheson BD, Homing SL, Coiffier B, et al. Report of an in- ternational workshop to standardize response criteria for non- Hodgkin's lymphomas. NCI Sponsored International Working Group [J]. J Clin Oncol, 2000, 18:2351 -2359.
  • 4Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas [ J]. Cancer, 1972, 29:252 - 260.
  • 5Kim JH, Lee SH, Park J, et al. Primary pulmonary non-Hodgkin's lymphoma [J]. Jpn J Clin Oncol, 2004, 34:510 -514.
  • 6Huang J, Lin T, Li ZM, et al. Primary pulmonary non- Hodgkin's lymphoma: a retrospective analysis of 29 cases in a Chinese population [J]. Am J Hematol, 2010, 85:523 - 525.
  • 7Yang HB, Li J, Shen T. Primary anaplastic large cell lymo phoma of the lung [J]. Acta Haematol, 2(107, 118; 188 - 191.
  • 8Coiffier B, Thieblemont C, Van Den Neste E, et al. Long- term outcome of patients in the LNH-98. 5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte [ J ]. Blood, 2010, 116:2040-2045.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部